Abstract:Abstract Background Chronic lesions of small blood vessels and capillaries may play a role in the pathogenesis of depression. As the genes associated with these vascular risk factors may be involved in depression, these genetic polymorphisms may affect the efficacy of antidepressants. This study was performed to investigate the roles of methylenetetrahydrofolate reductase (MTHFR), apolipoprotein E (ApoE), and apolipoprotein A4 (ApoA4) genetic polymorphisms in antidepressant response in depressive patients.Methods A total of 281 Han Chinese patients received a single antidepressant drug for at least 6 weeks. The Hamilton Depression Rating Scale (HAMD-17) was used to evaluate the severity of depressive symptoms and the therapeutic effects of the drug administered. Eight single nucleotide polymorphisms (SNPs) of MTHFR, ApoE, and ApoA4 genes were detected using gene chips. Differences in clinical variables between the responders and non-responders, as well as between remission and non-remission groups, were examined using the independent samples t test and Pearson’s χ 2 test. In addition, the associations of single loci and haplotypes with treatment response were analyzed.Results Among the eight SNPs in four genes, two SNPs (ApoA4 rs5101 and rs675) were eliminated as they had a MAF < 5%.Haplotype(C-A) in MTHFR (rsl801133 and rs1801131) was significantly associated with better antidepressant response in the 8-week antidepressant group overall ( P = 0.0007), and in the male subgroup ( P = 0.003), and serotonin norepinephrine reuptake inhibitor (SNRI) subgroup ( P = 0.001). The ApoE rs405509 C allele was significantly associated with poorer antidepressant response in the 6-week male subgroup ( P = 0.004), while the 405509 AA genotype was associated with better antidepressant efficacy in the 6-week antidepressant group overall ( P = 0.006) and male subgroup ( P = 0.002).Conclusions Genetic polymorphisms of MTHFR, ApoE, and ApoA4 may be associated with the efficacy of antidepressants, in which the haplotype (rs1801131-rs1801133) A–C type was associated with better antidepressant efficacy, especially in males and in patients using SNRIs. The efficacy of antidepressants may be better in ApoE rs405509 A allele and AA genotype carriers, but worse in ApoA4 rs5092 G allele and GG genotype carriers.

Association of APC and REEP5 Gene Polymorphisms with Major Depression Disorder and Treatment Response to Antidepressants in a Han Chinese Population

ABCB6, ABCB1 and ABCG1 Genetic Polymorphisms and Antidepressant Response of SSRIs in Chinese Depressive Patients.

Association of tryptophan hydroxylase 2 gene polymorphisms with major depression disorder and antidepressant treatment response

The Relationship Between Single Nucleotide Polymorphisms in 5-HT2A Signal Transduction-Related Genes and the Response Efficacy to Selective Serotonin Reuptake Inhibitor Treatments in Chinese Patients with Major Depressive Disorder

Epistatic Interaction Between 5-HT1A and Vascular Endothelial Growth Factor Gene Polymorphisms in the Northern Chinese Han Population with Major Depressive Disorder

Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response

[Association of TPH2 Gene Polymorphism with Response to Antidepressant Treatment among Ethnic Han Chinese Population].

Association Between 5-HTR1A Gene C-1019G Polymorphism and Antidepressant Response in Patients with Major Depressive Disorder: A Meta-Analysis

Association Study Between 5-HT2A and NET Gene Polymorphisms and Recurrent Major Depression Disorder in Chinese Han Population.

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated with Antidepressant Efficacy in Major Depressive Disorder

Catecholamine Pathway Polymorphisms and Antidepressant Response.

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response

Association of single nucleotide polymorphisms and gene-environment interactions with major depressive disorder in Chinese

Association analysis of COMT/MTHFR polymorphisms and major depressive disorder in Chinese Han population.

Influence of genetic polymorphisms involved in the hypothalamic-pituitary-adrenal axis and their interactions with environmental factors on antidepressant response.

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.

Association Study of Multidrug Resistance 1 Gene Polymorphisms with Efficacy and Adverse Drug Reaction of Paroxetine in Major Depressive Patients

[Association of CHRNA4 Gene Polymorphisms with Response to Antidepressant among Ethnic Han Chinese].

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

Polymorphisms of COMT and CREB1 are associated with treatment-resistant depression in a Chinese Han population